[go: up one dir, main page]

MX2010002592A - Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides. - Google Patents

Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.

Info

Publication number
MX2010002592A
MX2010002592A MX2010002592A MX2010002592A MX2010002592A MX 2010002592 A MX2010002592 A MX 2010002592A MX 2010002592 A MX2010002592 A MX 2010002592A MX 2010002592 A MX2010002592 A MX 2010002592A MX 2010002592 A MX2010002592 A MX 2010002592A
Authority
MX
Mexico
Prior art keywords
fusidic acid
combination
corticosteroid
pharmaceutical composition
topical pharmaceutical
Prior art date
Application number
MX2010002592A
Other languages
English (en)
Inventor
Sen Nilendu
Akhilesh Dayanand Sharma
Kusum Dinkar Gole
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of MX2010002592A publication Critical patent/MX2010002592A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a composiciones tópicas farmacéuticas que incluyen un corticoesteroide y ácido fusídico. De manera más particular, el presente invento se refiere a compuestos tópicos farmacéuticos incluyendo mometasona o halobetasol o sus esteres y ácido fusídico, los procesos para preparar los anteriores y el uso de dichos compuestos para la prevención y tratamiento de infecciones cutáneas.
MX2010002592A 2007-09-10 2008-09-08 Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides. MX2010002592A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1725MU2007 2007-09-10
PCT/IN2008/000577 WO2009063493A2 (en) 2007-09-10 2008-09-08 Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid

Publications (1)

Publication Number Publication Date
MX2010002592A true MX2010002592A (es) 2010-03-30

Family

ID=40639282

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010002592A MX2010002592A (es) 2007-09-10 2008-09-08 Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.

Country Status (5)

Country Link
US (1) US20100240621A1 (es)
BR (1) BRPI0804749A2 (es)
MX (1) MX2010002592A (es)
RU (1) RU2470645C2 (es)
WO (1) WO2009063493A2 (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009310634B2 (en) * 2008-10-30 2013-05-09 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
WO2010106461A1 (en) * 2009-03-17 2010-09-23 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate and fluticasone propionate
WO2010106458A1 (en) * 2009-03-17 2010-09-23 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate and betamethasone valerate
WO2010106462A1 (en) * 2009-03-17 2010-09-23 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate and mometasone furoate
WO2010119384A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same
WO2010122494A1 (en) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and mometasone, and a process to make it
WO2010122492A1 (en) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
MX2009009884A (es) * 2009-09-15 2011-03-16 Laboratorios Senosiain S A De C V Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.
WO2011101829A2 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - betamethasone dipropionate and an antifungal agent - miconazole nitrate, and a process to make it
WO2011101825A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and clobetasone, and a process to make it
WO2011101824A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, miconazole, dexamethasone, and a process to make it
WO2011101831A2 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasone butyrate, and an antifungal agent -terbinafine hydrochloride and a process to make it
WO2011101826A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, terbinafine and dexamethasone, and a process to make it
WO2011101827A2 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasone butyrate, and an antifungal agent - miconazole nitrate, and a process to make it
WO2011101823A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, clotrimazole and dexamethasone, and a process to make it
WO2011101830A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
PH12012501666A1 (en) 2010-02-22 2012-11-05 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - betamethasone dipropionate, and a process to make it
WO2011101822A2 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, and a corticosteroid - dexamethasone acetate, and a process to make it
WO2012017370A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, betamethasone dipropionate, terbinafine hydrochloride and a process to make it
WO2012017382A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, miconazole nitrate and a process make it
WO2012017381A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, beclomethasone dipropionate, clotrimazole and a process to make it
WO2012017371A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clobetasole propionate, terbinafine hydrochloride and a process to make it
WO2012017369A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, betamethasone dipropionate, clotrimazole and a process to make it
WO2012017383A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer, beclomethasone dipropionate, terbinafine hydrochloride and a process to make it
WO2012017372A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating, biopolymer, clobetasol propionate, miconazole nitrate and a process to make it
WO2012017368A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
WO2012023079A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, fluticasone propionate, oxiconazole nitrate and a process to make it
WO2012023081A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - oxiconazole nitrate, and a process to make it
WO2012023082A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - terbinafine hydrochloride, and a process to make it
WO2012023078A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - dexamethasone acetate, and an antifungal agent - oxiconazole nitrate, and a process to make it
WO2012023080A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - fluticasone propionate, and an antifungal agent -terbinafine hydrochloride and a process to make it
WO2012023077A1 (en) 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasol propionate, and an antifungal agent - oxiconazole nitrate, and a process to make it
WO2012035378A1 (en) * 2010-09-14 2012-03-22 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate, and fluticasone propionate, a process to make the same and a method of treatment using it
WO2012035380A1 (en) * 2010-09-14 2012-03-22 Sulur Subramaniam Vanangamudi A novel dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate, a process to make the same, and a method of treatment using it
WO2012035376A1 (en) * 2010-09-14 2012-03-22 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate, miconazole and mometasone furoate
WO2012035375A1 (en) * 2010-09-14 2012-03-22 Sulur Subramaniam Vanangamudi A novel dermaceutical cream made using sodium fusidate and mometasone furoate, a process to make the same, and a method of treatment using it
WO2012035374A1 (en) * 2010-09-14 2012-03-22 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate
WO2012035381A1 (en) * 2010-09-14 2012-03-22 Sulur Subramaniam Vanangamudi A novel dermaceutical cream made using sodium fusidate and betamethasone valerate, a process to make the same, and a method of treatment using it
WO2012049545A1 (en) 2010-10-12 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
WO2012049542A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, mometasone as a corticosteroid and clotrimazol as antifungal agent, and a process to make it
WO2012049540A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate, a corticosteroid, and an antifungal agent, and incorporating a biopolymer, and a process to make it
WO2012049543A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
WO2012049539A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate, a corticosteroid, and an antifungal agent, and incorporating a biopolymer, and a process to make it
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения
US20140112959A1 (en) * 2012-10-18 2014-04-24 MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite Topical steroid composition and method
RU2548764C2 (ru) * 2013-01-25 2015-04-20 Открытое Акционерное Общество "Татхимфармпрепараты" Лекарственное средство для лечения дерматозов (варианты)
RU2538680C2 (ru) * 2013-03-12 2015-01-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения атопического дерматита и способ ее получения
AU2014326221A1 (en) * 2013-09-25 2016-04-28 Sun Pharmaceutical Industries Limited Propellant-free topical spray composition of halobetasol
CN104758242B (zh) * 2014-01-07 2019-10-29 四川海思科制药有限公司 一种夫西地酸钠软膏药物组合物及其制备方法
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
CN111904926B (zh) * 2014-09-10 2023-10-10 Gsk消费者健康有限责任公司 局部用双氯芬酸钠组合物
EA025105B1 (ru) * 2015-04-01 2016-11-30 Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция, содержащая мометазона фуроат и салициловую кислоту
WO2016199000A1 (en) * 2015-06-10 2016-12-15 Subramaniam Vanangamudi Sulur A medicinal cream made using halobetasol propionate and incorporating a biopolymer and a process to make it
WO2016199002A1 (en) * 2015-06-10 2016-12-15 Subramaniam Vanangamudi Sulur A medicinal cream made using mometasone furoate and incorporating a biopolymer and a process to make it
PL3310389T3 (pl) 2015-06-18 2020-11-30 Bausch Health Ireland Limited Kompozycje miejscowe zawierające kortykosteroidy i retinoidy do stosowania w leczeniu łuszczycy
WO2017091167A1 (en) 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Topical pharmaceutical composition comprising fusidic acid, isoconazole, dexpanthenol and hydrocortisone
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
CN116650399B (zh) * 2023-04-13 2025-09-05 福元药业有限公司 一种夫西地酸乳膏及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072531A (en) * 1960-09-21 1963-01-08 Leo Pharm Prod Ltd Antibiotic and therapeutic compositions thereof
NL7411402A (nl) * 1973-09-13 1975-03-17 Leo Pharm Prod Ltd Werkwijze voor het bereiden van een middel tegen arthritis.
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
CA1199273A (en) * 1982-07-15 1986-01-14 Ctibor Schindlery Anti-inflammatory composition
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US6127353A (en) * 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
GB2302807A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Method and composition for treating atopic eczema
US6103884A (en) * 1996-03-27 2000-08-15 The University Of Michigan Glycosylated analogs of fusidic acid
US5972920A (en) * 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
WO2002070537A2 (en) * 2001-03-08 2002-09-12 Leo Pharma A/S Fusidic acid derivatives
TR200201343A2 (tr) * 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
US7972780B2 (en) * 2004-02-18 2011-07-05 Guy's And St. Thomas' Nhs Foundation Trust ITPase gene polymorphisms associated with adverse drug reactions to azathioprine therapy
CA2565965A1 (en) * 2004-05-06 2006-07-27 Plexxikon, Inc. Pde4b inhibitors and uses therefor
DE102005037844A1 (de) * 2005-08-04 2007-04-05 Intendis Gmbh Wasserfreies Mehr-Phasen-Gel-System
KR20140079867A (ko) * 2005-10-31 2014-06-27 레오 파마 에이/에스 결정성 항생 물질의 제조
JP5243262B2 (ja) * 2005-12-23 2013-07-24 エピナミクス・ゲー・エム・ベー・ハー ポリウレタン群ヘアケア用皮膜形成ポリマーの使用、ならびに該ポリマーを含有する医薬製剤およびパッチの使用
RU2008135444A (ru) * 2006-02-02 2010-03-10 Лео Фарма А/С (Dk) Композиция для местного применения, содержащая антибактериальные вещества

Also Published As

Publication number Publication date
WO2009063493A2 (en) 2009-05-22
US20100240621A1 (en) 2010-09-23
RU2470645C2 (ru) 2012-12-27
WO2009063493A3 (en) 2009-10-22
RU2010108009A (ru) 2011-10-20
BRPI0804749A2 (pt) 2009-06-16

Similar Documents

Publication Publication Date Title
MX2010002592A (es) Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
WO2012075081A3 (en) High-strength testosterone undecanoate compositions
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
MX2010014041A (es) Una forma cristalina de posaconazol.
WO2007109192A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2008116135A3 (en) Topical formulations having enhanced bioavailability
MX2012006730A (es) Tiazolidinadionas moderadoras de receptores activados por proliferador de peroxizoma (ppar) y combinaciones para tratamiento de enfermedades neurodegenerativas y otras enfermedades metabolicas.
WO2015010054A3 (en) Neuroactive steroids, compositions, and uses thereof
WO2009147201A3 (en) Anti-inflammatory agents
WO2007109172A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
WO2007109154A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109160A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
MY167918A (en) Composition for use in the sublingual delivery of medicaments to humans
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
WO2007109182A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2007109201A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
IN2012DN01434A (es)
MX341220B (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
WO2010092088A3 (de) Verwendung von hydrophobin als spreitmittel
WO2015059463A3 (en) Treatment of beta-catenin related diseases8
HK1209054A1 (zh) 不含硷化剂的拉喹莫德调配物
WO2011088160A3 (en) Novel cyp17 inhibitors
WO2010062506A3 (en) Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors

Legal Events

Date Code Title Description
FG Grant or registration